N1 Technologies Inc (CE) (NTCHF) Cotización

Nano stock price

Hey Steve, are you and ROC gonna be cell buddies in prison.

You have to be the dumbest SEC criminal - continuing run scams and ALWAYS getting busted.

Guess my posts weren't TOS violations after all

EB

CALGARY, Oct. 18, 2017 /CNW/ - Alberta Securities Commission (ASC) staff have issued a Notice of Hearing alleging that Calgary residents Zulfikar Rashid, John Zang and Richard Moore, in conjunction with current or former U.S. residents Ashmit Patel, Jonathan Levy and Gregory Buczynski, engaged in what is commonly referred to as a "pump-and-dump" scheme. The scheme involved the penny stock of Kilimanjaro Capital Ltd. (now known as N1 Technologies Inc.), a former Alberta-based shell company. ASC staff also allege that Rashid and Zang obstructed justice and that Zang, Patel and Moore breached a cease trade order issued by the ASC in respect of Kilimanjaro.

The allegations have not been proven.

An appearance to set a date for a hearing will be held on December 13, 2017 at 1:00 p.m. in the ASC Hearing Room, 5th Floor, 250 – 5th Street S.W., Calgary, Alberta.

A copy of the Notice of Hearing can be found on the ASC website at www.albertasecurities.com.

The ASC is the regulatory agency responsible for administering the province's securities laws. It is entrusted with fostering a fair and efficient capital market in Alberta and with protecting investors. As a member of the Canadian Securities Administrators, the ASC works to improve, coordinate and harmonize the regulation of Canada's capital markets.

SOURCE Alberta Securities Commission


For further information: For Media Inquiries: Hilary McMeekin, Manager, Communications, 403.592.8186; For Investor Inquiries: ASC Public Inquiries, Toll Free 1.877.355.4488

Related Links

http://www.albertasecurities.com

NTCHF: SEC Charges Penny-Stock Operators in Push to Crack Down on Repeat Offenders

FOR IMMEDIATE RELEASE

2017-188

Washington D.C., Oct. 3, 2017—

The Securities and Exchange Commission today charged two individuals with defrauding investors in penny stock companies that claimed to have valuable patents. One of those charged had been barred from the penny stock business based on his role in another securities scheme and neither he nor his companies had ever been issued any patents by the U.S. Patent and Trademark Office, the SEC alleged.

The SEC’s complaint, filed in U.S. District Court for the Southern District of Florida, charged Rockey “Roc” G. Hatfield, of Safety Harbor, Florida, Steve E. Lovern, of Atlanta, Belize-based N1 Technologies Inc., and Wyoming-based NanoSave Technologies Inc. Hatfield is a repeat offender whose prior securities schemes resulted in a criminal conviction, injunctions, a contempt of court finding, and broker-dealer, investment adviser, and penny-stock bars. The SEC’s complaint alleges Hatfield controlled the two companies but concealed his role in them by having his wife and Lovern named as corporate officers and directors.

The U.S. Attorney’s Office for the Southern District of Florida today filed related criminal charges against Hatfield, Lovern, and others, and the SEC announced a trading suspension in NanoSave Technologies (NNSV).

According to the SEC’s complaint, the defendants hired unregistered brokers to cold call investors and pitch investments in “patent units,” using scripts written by Hatfield, including one that falsely claimed N1 Technologies had patented a cure for staph infections. Investors were told that purchasing an $80,000 unit could yield as much as $1 million based on sales of similar patents, the SEC alleged. The SEC alleged that although investors were told that their money would help fund further research and development, the defendants used most of it for personal expenditures and to pay sales commissions of up to 40 percent.

“As alleged in our complaint, Hatfield is a recidivist who fraudulently raised money by selling investors interests in non-existent patents,” said Eric I. Bustillo, Director of the SEC’s Miami Regional Office. “This action is part of the Miami Regional Office’s Recidivist Initiative and the Commission’s efforts to pursue recidivist violators and hold them accountable.”

The SEC is seeking return of the defendants’ allegedly ill-gotten gains, with interest, a civil monetary penalty, a court injunction, and other relief.

The SEC’s investigation, which is continuing, is being conducted by Jordan A. Cortez and Mark Dee in the Miami Regional Office. The case is being supervised by Eric. R. Busto and the SEC’s litigation is being led by Alejandro Soto. The SEC appreciates the assistance of the U.S. Attorney’s Office for the Southern District of Florida, the Federal Bureau of Investigation’s Miami Field Office, and the Financial Industry Regulatory Authority.

###

https://www.sec.gov/news/press-release/2017-188

NTCHF buy 0.0900

bull flag
bullish divergence breakout, initial pullback
stochastics exiting oversold
moving average golden cross pattern

normal chart




log chart

get ready for a pumpy dumpy tomorow

Yup take profits nothingvwrong with that

Either way, hope u made your profits, you were warned$$$$$

Using false information is fraud....... and ProTrader and PTE are committing fraud as $NTCHF has nothing to do with nanotech as per it new ticker owner Hugo Santos and their website

About
N1 Technologies Inc. is a Belize international business company listed on the OTC markets Pink Sheets. For more information see:

OTC Pink Sheet NTCHF

Not affiliated with N1 Technologies Corp or NanoSave Technologies Inc.

Early spike in the morning $$$$$

PTE LLC has been compensated up to Thirty-Five Thousand Dollars Cash via bank wire transfer by a third party (ACN) for a 2 Day Marketing Program regarding NTCHF

New scumbag owner of ticker since the others moved on..... couldn't stand the heat.

NTCHF -is stock guru's NEW IPO Style MONSTER Play for TOMORROW!

N1 Technologies Posts Strong Q3 Results
N1 Technologies released news reporting
on the company's New direction. PR here:
http://www.prnewswire.com/news-releases/n1-technologies-inc-posts-strong-3q-results-300357390.html

Breaking News N1 Technologies Posts Q3 Results
N1 Technologies released news today reporting
on the company's New Mission. PR here:
http://www.prnewswire.com/news-releases/n1-technologies-inc-posts-strong-3q-results-300357390.html

Strong Q3 Results for N1 Today
N1 Technologies Q3. Assets increased
dramatically due to 2 new biotech patents. Q3 Report:
http://www.otcmarkets.com/financialReportViewer?symbol=NTCHF&id=162036

N1 Technologies reporting strong Q3 Results Today
The company had a very productive Q3. Assets climbed
dramatically. Q3 Report:
http://www.otcmarkets.com/financialReportViewer?symbol=NTCHF&id=162036

N1 Technologies files a new Patent.
N1 Technologies has filed a new patent with the USPTO
for a BioPhage based testing kit for both Staph and Strep
bacterial infections. The test can detect the presence of
bacteria in an hour and can be seen by the human eye.
www.N1Technologies.com

N1 Technologies files a new Patent.
N1 Technologies has filed a new patent with the USPTO
for a BioPhage based testing kit for both Staph and Strep
bacterial infections. The test can detect the presence of
bacteria in an hour and can be seen by the human eye.
www.N1Technologies.com

New BioPhage based Testing Kit Patent Filed.
N1 Technologies announcing the filing of a new BioPhage based
Testing Kit Patent. The new product is a mini lab for the onsite
testing for the presence of Staph and Strep bacteria. The company
hopes to market the test kits in conjunction with there BioPhage
based Staph and Strep biopharmaceuticals.
www.N1Technologies.com

Fully Granted Patents Take 3 Years
A fully granted U.S. Patent Number can take 3 years.
Of course everyone will be excited when the Viritron Technology
is granted a final patent. But no one will be able to buy
shares @.21 then. Buy low, Sell high!

Again, when I see a patent #, then I'll get excited.

VIRITRON VDX Patent Filed # 62337370
Electronic filing# 25796072 Docket# TPP30364
More info here: www.N1Technologies.com

N1 Technologies secures research lab in Poland
N1 Technologies is now working with Phage Consultants
in Poland. Both companies are working on developing a
research schedule for the Viritron VDX program.
www.N1Technologies.com

N1 Technologies files new Viritron Patent
New press Release out today! N1 Technologies
files a new Viritron Patent for Pneumonia treatment,
adding to its biopharmaceutical line up.
http://www.otcmarkets.com/stock/NTCHF/news/N1-Technologies-Patents-VIRITRON-VPN-Pneumonia-Treatment?id=139141&b=y

NTCHF:

Viritron VDX Patent info filed with USPTO
Viritron VDX filed, Patent App # 62337370
Electronic filing# 25796072 Docket# TPP30364
More info here: www.N1Technologies.com

When they provide a patent number, then I'll get excited

NTCHF:

NEWS! New Viritron Patent Filed with USPTO
The company recently filed a new Viritron patent.
Viritron VPN is a new biopharmaceutical aimed at the
bacteria that causes Pneumonia.
http://www.otcmarkets.com/stock/NTCHF/news/N1-Technologies-Patents-VIRITRON-VPN-Pneumonia-Treatment?id=139141&b=y


N1 Technologies moving forward with leading lab
The company announcing it is working with a leading Biophage
research lab, Phage Consultants located in Poland. Both
companies to team up on the research and development of
the Viritron VDX and Viritron VPN biopharmaceuticals.

Big News Out Today! N1 Technologies PR
N1 Technologies files New Biotech Patent
The company is focusing on the biotech arena.
http://www.prnewswire.com/news-releases/n1-technologies-inc-files-new-biotech-patent-300308022.html

NTCHF:

N1 Technologies moving into Biotech
New Presser today outlines the company's entry
into the Biotech space. New patent filed for a Staph infection treatment.
http://www.prnewswire.com/news-releases/n1-technologies-inc-files-new-biotech-patent-300308022.html

NTCHF:

Q2 Financial Results are up on OTC today!
N1 Technologies posts their second quarter financial results
today. Looks like another solid quarter for the company.
http://www.otcmarkets.com/financialReportViewer?symbol=NTCHF&id=157800

N1 Technologies just posted their Q2 Financial Results
N1 Technologies posting their Q2 Results on the OTC site today.
http://www.otcmarkets.com/financialReportViewer?symbol=NTCHF&id=157800

N1 Technologies seeking San Francisco Biotech VC money
N1 Technologies is currently seeking major biotech VC capital
for its VIRITRON VDX Genetically Modified Bacteriophage aimed
at treating Staph infections. www.ViritronVDX.com

N1 Tech launches new high powered website
N1 Technologies has re-branded its website and
now is tightly focused on the Bio-Tech industry.
The company is working on treatments for bacterial Staph and
Pneumonia infections. http://www.N1Technologies.com

Brand new N1 Technologies website is up!
The company is re-focusing itself on Nano Bio Tech
products. Huge potential in this arena. http://www.N1Technologies.com

Big new changes at N1 Technologies
N1 Technologies announcing it is re-branding itself as a Nano Bio Technology
company. The company is focusing on 2 recent Bio Tech discoveries and
sees them as the future of the company. http://www.ViritronVDX.com

N1 Technologies focusing on Bio Tech Research
N1 Technologies is rebranding itself as a Nano and Bio Technology
company. The company has patented a new Bio Tech discovery that
has amazing potential for patients and investors. http://www.ViritronVDX.com

Viritron VDX Deal being funded by Dallas Capital Group
Patent Capital Group working with N1 Technologies to help
with funding the company's Viritron VDX GMO product.
http://www.PatentCapitalGroup.com http://www.ViritronVDX.com

N1 Technologies contracting with Dallas patent firm.
N1 Technologies is working with Dallas TX. based
Patent Capital Group. PCG will assist with funding the
Viritron VDX program. http://www.ViritronVDX.com

big splash on Twitter

Roc where do you come up with this sht?

11 total tweets EVER.

No wonder the guy was busted by the SEC repeatedly, what a computer generated scam artist

Viritron VDX makes big splash on Twitter
N1 Technologies announced the filing of a patent for
their new Viritron VDX bio-tech product on Twitter
generating a lot of Buzz. www.Twitter.com/N1Technologies

N1 Technologies launches new VIRITRON VDX website.
N1 Technologies launched a new website today. The site
is for the company's newest Bio-Tech product Viritron VDX.
A Genetically Modified Organism that targets Staph infections.
http://www.ViritronVDX.com

New VIRITRON VDX Video up on YouTube!
Wow! Checkout this new video from N1 Technologies.
The company has a big winner here.

Big News on Bio-Tech Product Coming
Big News on a patent filing for a promising
treatment for Staph infections. The product
is called Viritron VDX https://www.facebook.com/N1Technologies

Steve?!?!? Nobody is obsessed with you except you! You're an enigma. You have been buying your own hype for way too long!

Twitter Blows up with N1 Technologies News!
N1 Technologies released news on Twitter today
about their new Bio_Tech discovery. Viritron VDX
is a GMO that fights Staph infections.
https://twitter.com/N1Technologies

N1 Technologies announcing new patent filing.
Big News! N1 Technologies has just filed a patent with the
USPTO for a new Bio-Tech discovery. Viritron VDX is
a Genetically Modified Organism or GMO.
http://www.otcmarkets.com/financialReportViewer?symbol=NTCHF&id=155033

N1 Technologies announcing a new Bio-Tech discovery.
The company has filed an initial patent with the USPTO. The discovery is a natural nano scale
virus that has been modified to be highly effective at treating Staph infections.
The invention or GMO is called Viritron VDX. Huge Potential!
https://www.facebook.com/N1Technologies

Company Posts Q1 Financial Results.
The first quarter results look great.
You can see them here: http://www.otcmarkets.com/financialReportViewer?symbol=NTCHF&id=155033

Steve you seem extremely obsessed with me, maybe you should ask 1 of your followers who I am........... Oh yeah, no followers and you only post on the two tickers run by the Clearwater scamsters.

On the positive side, they are not dumping shares.........YET.